Terms of trade, revealed comparative advantage, NTB, MFN - jargon which has underpinned global trade over the past thirty ...

The Arizona congressional delegation should stand up for our bioscience sector and oppose any policy like Most Favored Nation ...

The U.S. government has been discussing with drugmakers how to raise overseas drug prices as President Donald Trump seeks to ...

Following a barrage of letters from President Donald Trump urging 17 large pharmaceutical companies to implement Most Favored ...

Made-ups, including bed linen and towels, will face a 59 per cent duty on USD 3 billion worth of exports. Diamonds, gold, and ...

Lilly has been chasing—and gaining on—its chief metabolic medicine rival Novo Nordisk and its counterpart GLP-1s Ozempic and ...

Meanwhile, drugmakers ramp up U.S. manufacturing investments to navigate policy shifts and protect supply chain resilience.

Trump's Bold Steps to Lower Prescription Drug Prices Ignite Hope** In a powerful move to alleviate the financial burden on American families, President Donald Trump has signed a ...

German drugmaker Merck KGaA on Thursday joined peers in saying it was considering distribution models that serve U.S.

The threat comes as Trump's administration pressures pharmaceutical companies to lower drug prices for Americans.

Bio-Techne on Wednesday said it expects uncertainty related to U.S. President Donald Trump's tariff and academic funding policies to spill into its fiscal year 2026 and could create pressure on the ...

George Tidmarsh takes over temporarily at CBER following Vinay Prasad’s abrupt departure; Replimmune trial leaders protest ...